Table 3.
Mean Value and Standard Deviation (SD) of eGFR According to Combination of Obesity Indices and Dyslipidemia
| Male | Female | |||||
|---|---|---|---|---|---|---|
| Mean±SD | Pt-test | Ptrend | Mean±SD | Pt-test | Ptrend | |
| Dyslipidemia (-) High BMI (-) | 116.984±19.025 | (ref.) | 0.002 | 170.041±54.388 | (ref.) | 0.233 |
| Dyslipidemia (+) High BMI (-) | 113.951±23.561 | 0.118 | 161.085±63.324 | 0.119 | ||
| Dyslipidemia (-) High BMI (+) | 104.211±16.926 | 0.009 | 157.313±29.608 | 0.086 | ||
| Dyslipidemia (+) High BMI (+) | 107.307±17.176 | <0.001 | 161.952±37.666 | 0.275 | ||
| Dyslipidemia (-) High WHR (-) | 116.149±22.423 | (ref.) | 0.544 | 177.356±56.948 | (ref.) | 0.014 |
| Dyslipidemia (+) High WHR (-) | 110.127±16.957 | 0.046 | 169.778±102.491 | 0.647 | ||
| Dyslipidemia (-) High WHR (+) | 114.705±17.379 | 0.474 | 161.646±47.640 | 0.002 | ||
| Dyslipidemia (+) High WHR (+) | 112.566±23.103 | 0.045 | 158.242±33.453 | <0.001 | ||
| Dyslipidemia (-) High VFA (-) | 116.915±20.594 | (ref.) | 0.058 | 169.079±55.821 | (ref.) | 0.225 |
| Dyslipidemia (+) High VFA (-) | 114.831±20.972 | 0.456 | 163.444±72.288 | 0.462 | ||
| Dyslipidemia (-) High VFA (+) | 113.344±17.546 | 0.137 | 167.114±32.090 | 0.740 | ||
| Dyslipidemia (+) High VFA (+) | 111.124±22.614 | 0.002 | 157.936±31.875 | 0.009 | ||
| Dyslipidemia (-) High SFA (-) | 116.025±19.536 | (ref.) | 0.045 | 172.034±61.533 | (ref.) | 0.043 |
| Dyslipidemia (+) High SFA (-) | 112.807±21.902 | 0.052 | 165.845±71.915 | 0.419 | ||
| Dyslipidemia (-) High SFA (+) | 108.791±15.443 | 0.117 | 162.337±26.665 | 0.007 | ||
| Dyslipidemia (+) High SFA (+) | 107.918±23.915 | 0.090 | 154.524±33.254 | <0.001 | ||
Abbreviations: VFA, visceral fat area; SFA, subcutaneous fat area; BMI, body mass index; WHR, waist-hip ratio; eGFR, estimated glomerular filtration rate.